Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Conley

Showing results (141-150 of 281) with videos related to

Pageof 29
Sort By:
Journal of the Royal Society, Interface|November 21, 2023
The hydrodynamics and kinematics of the appendicularian tail underpin peristaltic pumpingTerra C Hiebert, Brad J Gemmell, George von Dassow, et al.
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case studyRobert R Conley, Deanna L Kelly, Lori L Beason-Held, et al.
CNS Drugs|March 24, 2026
Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept TrialMathieu Seynaeve, Fiona Dunbar, Chandni Hindocha, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2011
Sensing cooperativity in ATP hydrolysis for single multisubunit enzymes in solutionYan Jiang, Nicholai R Douglas, Nicholas R Conley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trialsRobert P McMahon, Deanna L Kelly, Julie Kreyenbuhl, et al.
Archives of General Psychiatry|March 7, 1998
Specific measures account for most of the variance in qualitative ratings of smooth pursuit eye movements in schizophreniaD E Ross, G K Thaker, R W Buchanan, et al.
The International Journal of Neuropsychopharmacology|September 19, 2006
Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampusGhanshyam N Pandey, Yogesh Dwivedi, Xinguo Ren, et al.
JAMA Neurology|May 30, 2018
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical TrialVirginia L Stauffer, David W Dodick, Qi Zhang, et al.
Biological Psychiatry|December 24, 2008
Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesisWilliam T Regenold, Pornima Phatak, Christopher M Marano, et al.
Comprehensive Psychiatry|November 9, 2005
Cardiovascular disease in relation to weight in deceased persons with schizophreniaRobert R Conley, Joo-Cheol Shim, Deanna L Kelly, et al.
Pageof 29

Showing results (141-150 of 281) with videos related to

Sort By:
Pageof 29
Journal of the Royal Society, Interface|November 21, 2023
The hydrodynamics and kinematics of the appendicularian tail underpin peristaltic pumpingTerra C Hiebert, Brad J Gemmell, George von Dassow, et al.
Journal of Psychopharmacology (Oxford, England)|September 11, 2004
The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case studyRobert R Conley, Deanna L Kelly, Lori L Beason-Held, et al.
CNS Drugs|March 24, 2026
Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept TrialMathieu Seynaeve, Fiona Dunbar, Chandni Hindocha, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2011
Sensing cooperativity in ATP hydrolysis for single multisubunit enzymes in solutionYan Jiang, Nicholai R Douglas, Nicholas R Conley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trialsRobert P McMahon, Deanna L Kelly, Julie Kreyenbuhl, et al.
Archives of General Psychiatry|March 7, 1998
Specific measures account for most of the variance in qualitative ratings of smooth pursuit eye movements in schizophreniaD E Ross, G K Thaker, R W Buchanan, et al.
The International Journal of Neuropsychopharmacology|September 19, 2006
Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampusGhanshyam N Pandey, Yogesh Dwivedi, Xinguo Ren, et al.
JAMA Neurology|May 30, 2018
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical TrialVirginia L Stauffer, David W Dodick, Qi Zhang, et al.
Biological Psychiatry|December 24, 2008
Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesisWilliam T Regenold, Pornima Phatak, Christopher M Marano, et al.
Comprehensive Psychiatry|November 9, 2005
Cardiovascular disease in relation to weight in deceased persons with schizophreniaRobert R Conley, Joo-Cheol Shim, Deanna L Kelly, et al.
Pageof 29